Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep;24(9):2349-53.
doi: 10.1093/annonc/mdt191. Epub 2013 May 22.

A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy

Affiliations

A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy

Z-Q Jiang et al. Ann Oncol. 2013 Sep.

Abstract

Background: Whether carcinomas of the ampulla of Vater should be classified with biliary tract tumors and treated in a similar manner remains unknown. We sought to compare the outcomes of similarly staged periampullary adenocarcinomas (AAs) and analyze the chemotherapy responsiveness of AAs.

Patients and methods: A total of 905 patients with resected periampullary adenocarcinomas were identified from a prospective surgical registry from 1988 to 2010. A second cohort of 64 metastatic AA patients from 1992 to 2009 who received either front-line fluoropyrimidine-based or gemcitabine-based chemotherapy was also identified.

Results: Overall survival (OS) for AAs was similar to survival with duodenal adenocarcinomas, but was significantly different from both extrahepatic biliary and pancreatic adenocarcinomas (P < 0.001 for each comparison). In multivariate analysis, AAs had a significantly improved OS in comparison with extrahepatic biliary adenocarcinomas (HR = 1.97, P = 0.006). Fluoropyrimidine-based as opposed to gemcitabine-based chemotherapy for metastatic AAs resulted in a significant improvement in time to progression (P = 0.001) but only a trend toward benefit for OS (P = 0.07) in multivariate analysis.

Conclusions: Differences in the natural history of ampullary and extrahepatic biliary adenocarcinomas exist. Analyses of metastatic ampullary adenocarcinomas suggest that fluoropyrimidine-based chemotherapy may represent a more appropriate front-line chemotherapy approach.

Keywords: ampullary adenocarcinomas; chemotherapy; fluoropyrimidine; gemcitabine; periampullary.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Overall survival (OS) for 905 resected periampullary adenocarcinoma cases stratified by tumor type: (A) all, (B) Lymph node-positive cases, (C) Lymph node-negative cases, (D) T1-T2 cases, (E) T3-T4 cases.
Figure 2.
Figure 2.
Outcomes for 64 metastatic ampullary adenocarcinoma patients treated with either first-line fluoropyrimidine-based or gemcitabine-based chemotherapy: (A) time to progression (TTP) and (B) OS.

References

    1. Yeo CJ, Sohn TA, Cameron JL, et al. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg. 1998;227:821–831. doi:10.1097/00000658-199806000-00005. - DOI - PMC - PubMed
    1. Albores-Saavedra J, Schwartz AM, Batich K, et al. Cancers of the ampulla of vater: demographics, morphology, and survival based on 5625 cases from the SEER program. J Surg Oncol. 2009;100:598–605. doi:10.1002/jso.21374. - DOI - PubMed
    1. Nathan H, Pawlik TM, Wolfgang CL, et al. Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointest Surg. 2007;11:1488–1496. discussion 1496–1487 doi:10.1007/s11605-007-0282-0. - DOI - PubMed
    1. Kimura W, Futakawa N, Yamagata S, et al. Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater. Jpn J Cancer Res. 1994;85:161–166. doi:10.1111/j.1349-7006.1994.tb02077.x. - DOI - PMC - PubMed
    1. Kohler I, Jacob D, Budzies J, et al. Phenotypic and genotypic characterization of carcinomas of the papilla of Vater has prognostic and putative therapeutic implications. Am J Clin Pathol. 2011;135:202–211. doi:10.1309/AJCPCTCUQSYI89YT. - DOI - PubMed

Publication types

MeSH terms